One Battle After Another: Broad Institute Wins at PTAB in CRISPR Dispute
Key Takeaways: Interference proceedings, though increasingly rare, are heavily evidence-based and determine which party is the first inventor when two or more applicants claim the same patentable invention. Sometimes, an...
Challenged Director-To-PTAB Instructions Did Not Require Notice-And-Comment Rulemaking
APPLE INC. v. SQUIRES Before Lourie, Taranto, and Chen. Appeal from the United States District Court for the Northern District of California. Summary: Challenged instructions that the PTO’s Director gave...
PTAB to Rehear Ex Parte Baurin: Revisiting the Interplay of Obviousness-Type Double Patenting and Patent Term Adjustment After Cellect and Allergan
Key Takeaway: The PTO Director’s sua sponte rehearing of Ex parte Baurin raises questions regarding the scope of Allergan v. MSN, Examiners’ role in obviousness-type double patenting rejections, and the...
Subscribe for News and Updates